Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

820 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hospital Epidemics Tracker (HEpiTracker): Description and pilot study of a mobile app to track COVID-19 in hospital workers.
Soriano JB, Fernández E, de Astorza Á, Pérez de Llano LA, Fernández-Villar A, Carnicer-Pont D, Alcázar-Navarrete B, García A, Morales A, Lobo M, Maroto M, Ferreras E, Soriano C, Del Rio-Bermudez C, Vega-Piris L, Basagaña X, Muncunill J, Cosio BG, Lumbreras S, Catalina C, Alzaga JM, Gómez Quilón D, Valdivia CA, de Lara C, Ancochea J. Soriano JB, et al. Among authors: lobo m. JMIR Public Health Surveill. 2020 Sep 21;6(3):e21653. doi: 10.2196/21653. JMIR Public Health Surveill. 2020. PMID: 32845852 Free PMC article.
Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1.
Hernández-Breijo B, Monserrat J, Román ID, González-Rodríguez Á, Fernández-Moreno MD, Lobo MV, Valverde ÁM, Gisbert JP, Guijarro LG. Hernández-Breijo B, et al. Among authors: lobo mv. Toxicol Appl Pharmacol. 2013 Nov 1;272(3):568-78. doi: 10.1016/j.taap.2013.07.024. Epub 2013 Aug 16. Toxicol Appl Pharmacol. 2013. PMID: 23958494
Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension.
Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, Murphy K, Boer JH, van Keep M, Ta AT, Barman NC, Schwab G, Akehurst R, Schmieder RE. Taylor RS, et al. Among authors: lobo md. Pharmacoecon Open. 2024 May 8. doi: 10.1007/s41669-024-00485-8. Online ahead of print. Pharmacoecon Open. 2024. PMID: 38717555 No abstract available.
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Moser JC, Bhatia S, Amin A, Pavlick AC, Betts KA, Du EX, Poretta T, Shelley K, Srinivasan S, Sakkal LA, Palaia J, Lobo M, Pe Benito M, Linton JA, Chen Y, Xu C, Yin L, Sundar M, Weber J. Moser JC, et al. Among authors: lobo m. Cancer Immunol Immunother. 2024 May 7;73(7):116. doi: 10.1007/s00262-024-03697-3. Cancer Immunol Immunother. 2024. PMID: 38713408 Clinical Trial.
820 results